Jeffrey V. Matous, MD

Articles by Jeffrey V. Matous, MD

Frequency of Measuring Treatment Response in MM

ByRobert Z. Orlowski, MD, PhD,Larry Anderson, MD, PhD,Caitlin Costello, MD,Jeffrey V. Matous, MD

September 15th 2021

Recommendations for measuring treatment response in patients with multiple myeloma utilizing tests such as MRD assessments.

Strategies to Monitor Multiple Myeloma

ByRobert Z. Orlowski, MD, PhD,Larry Anderson, MD, PhD,Caitlin Costello, MD,Jeffrey V. Matous, MD

September 10th 2021

Different markers and tests that are used to monitor disease status and treatment response in patients with multiple myeloma.

Goals of Therapy for Transplant-Ineligible MM

ByRobert Z. Orlowski, MD, PhD,Larry Anderson, MD, PhD,Caitlin Costello, MD,Jeffrey V. Matous, MD

September 8th 2021

Kicking off a discussion regarding treatment approaches for transplant-ineligible multiple myeloma, a panel of hematologist-oncologists highlights goals of therapy for newly diagnosed patients.

Jeffrey V. Matous, MD

Articles by Jeffrey V. Matous, MD

Frequency of Measuring Treatment Response in MM

Strategies to Monitor Multiple Myeloma

Goals of Therapy for Transplant-Ineligible MM

Trending on CancerNetwork

FDA Approves Revumenib in R/R NPM1-Mutant AML

ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

FDA Grants BTD to Zenocutuzumab in NRG1+ Cholangiocarcinoma